Transcript Meningitis

Meningitis - What Every
Teen Needs to Know
Stacy A. Morehead, RN, BSN
Whitney Benson, RN, BSN
Good Samaritan Hospital
Objective
• Upon completion of this lecture,
participants will be able to :
– Describe the meningitis disease process
– Define causes, manifestations, and
medical care
– Explain preventative measures.
4/12/2016
2
Meningitis
• Definition: an
inflammation of the
meninges, the
protective
membrane that
surround the brain
and spinal cord.
4/12/2016
3
Meninges
• Dura
• Arachnoid
• Pia
http://www.nlm.nih.gov/medlineplus/ency/imagepages/19080.htm
Dura
• Thick non-elastic
structure
• Lines the inside of the
skull and the vertebral
column
• Blood supply
– External carotid
artery
– Middle meningeal
artery
• Falx Cerebri
• Tentorium Cerebelli
Arachnoid
• Arachnoid Villi
– Responsible for
reabsorption of
CSF
– Transfer of CSF to
venous system
Pia Mater
• Thin, transparent
membrane adherent
to the surface of the
brain
Subtypes
• Aseptic: the cause is viral or due to
lymphoma, leukemia, or brain abscess
• Septic: caused by bacteria
– Streptococcus pneumoniae = pneumococcal
meningitis
– Neisseria meningitidis = meningococcal
meningitis
– Haemophilus influenzae = Hib meningitis
Causes
– Through the bloodstream as a consequence
of other infections:
• Otitis Media & mastoiditis
• Infected shunt
• Recent dental surgery
– Traumatic injury to the facial bones
– Secondary to invasive procedures
• Contaminated lumbar puncture
4/12/2016
9
Bacterial Meningitis
• Peak incidence is in winter and early spring
• Who is at higher risk?
• Populations in dense community groups ie: college
campuses and military
• Tobacco users
• Viral upper respiratory infections
• Immune system deficiencies
– AIDS
– Lyme Disease
– Organ transplantation
4/12/2016
10
Signs and Symptoms
Classic Triad
– Headache
– Fever
– Nuchal rigidity (stiff neck)
Nausea/ vomiting
Photophobia
Rash
Disorientation and memory impairment
Behavioral changes
Seizures and increased ICP
4/12/2016
11
Signs and Symptoms (continued)
4/12/2016
12
Diagnostic Testing
• Lumbar puncture
• CSF studies: cell count, protein and glucose
levels, culture, cytological analysis, and Gram’s
staining
• Cultures: blood, sputum, nasopharyngeal
specimen, rash aspirate
• Hematology: chemistry and coagulation panels
• Serology (antigen tests)
• CT of head
• Chest & sinus Xray
• EEG
4/12/2016
13
CT Scan
• Head CT
demonstrates
enlargement of the
temporal horns
indicating increased
intracranial pressure.
• Small intracerebral
hemorrhage foci on
the right temporal
lobe
• The effect of
increased intracranial
pressure on the
EEG
• An electroencephalogram (EEG) study is
sometimes useful to document irritable
electrical patterns that may predispose the
patient to seizures.
Lumbar Puncture
• Involves the introduction of a
hollow needle with a stylet
onto the lumbar subarachnoid
space of the spinal canal using
strict aseptic technique.
– Adult landmarks L3-L4 or L4L5
4/12/2016
• Therapeutic indications
– Spinal anesthesia
– Intrathecal injection
– Removal of CSF to reduce
pressure
• Diagnostic indications
– Measurement of CSF
pressures
– Collection of sample for
cytologic, chemical, and
bacterial examination
– Evaluation of spinal
dynamics for signs of
blockage of CSF flow
– Injection of radiopaque
media for visualization of
parts of the nervous system
16
• Help the patient lay on their side along the edge of the bed,
arching the back so that the knees are flexed on the chest
with the chin touching the knees.
• The lumbar site is prepared, draped, and locally
anesthetized.
• The needle is introduced into the appropriate subarachnoid
space, the stylet is removed, and a manometer is affixed to
measure and record opening pressures.
• The manometer is removed and samples of CSF are
collected into sterile test tubes for visual and laboratory
examination.
• When the procedure is completed, the needle is removed,
and a Band-Aid is applied directly over the puncture site.
• Tubes are labeled according to draw order and promptly
hand delivered to lab.
4/12/2016
17
• Post procedural care
– Have patient lay flat in bed for 6-8 hours
– Monitor neurological and vital signs frequently
– Encourage fluids
– Administer pain medications as needed
– Monitor puncture site
– Notify physician of severe headache, voiding
problems, nuchal rigidity, rise in temperature,
or back spasms
4/12/2016
18
CSF Values Diagnostic for Meningitis
Parameter
Normal CSF
Bacterial
Meningitis
Viral Meningitis
Culture
Negative
Positive
Color
Straw colored
Cloudy, purulent
Leukocyte count
(wbc/mm3)
0-5
Increased
1000-5000
Increased
50-1000
Protein (mg/dL)
18-45
Elevated
100-500
Normal or
Elevated
<200
Glucose (ml/dL)
45-80; 0.6 times
blood glucose
level
5-40;
low levels
>45
normal
4/12/2016
negative
19
Nursing Management
•
•
•
•
Vital signs, Intake/Output
Advanced neurological assessment, GCS
Monitoring of lab values
Protect patient from injury secondary to seizure
of altered level of consciousness
• Isolation precautions
– Droplet precautions
• Administration of antibiotics, IV fluids,
corticosteroids, and antiepileptic medications
4/12/2016
20
Medical Treatment
• Bacterial
– Broad spectrum
antibiotics until
organism is identified
– Corticosteroids may
be used for
inflammation
– Consultation with
infectious disease,
neurosurgery
• Viral
– Antiviral drugs
(Acylcovir)
– May resolve without
specific treatment
– Supportive therapy
Outcomes
• Most patients with meningococcal meningitis
recover completely if appropriate antibiotic
therapy is instituted promptly.
• The prognosis for meningococcal meningitis is
fair if the patient does not have focal neurologic
deficits and is not stuporous or comatose.
• The prognosis for meningococcal disease is
poor when the infection has a septicemic
component.
Potential Complications
•
•
•
•
•
Hearing or vision loss
Seizures
Brain Abscess
Hydrocephalus
Respiratory
complications
• Weight loss, nausea,
fatigue
Prevention
• Vaccination
• Antimicrobial chemoprophylaxis should be
given to anyone in close contact with
patients diagnosed with meningococcal
meningitis
4/12/2016
24
Case Study
• Drey Mingo
–
–
–
–
–
–
Hometown: Atlanta, GA
Co-Captain
Senior at Purdue
Position: Forward
Height: 6’2”
Named third team All-Big
Ten by coaches
– Set school season record
for three-point field goal
percentage
– Named to the Preseason
WNIT All-Tournament Team
Case Study Update
• I didn’t know just how bad I was until afterwards.
I don’t think people wanted to freak me out
because I was still kind of fragile in that moment
in time… It’s crazy how bad things could have
been and just where I am now, I am so thankful.”
• “Knowing that I can’t hear as well as them, I
think that will be a definite challenge. I actually
recently went to the doctor and from my first
hearing test – I just had a recent hearing testmy hearing has improved more than they
thought. They just didn’t think that it would get
any better at all.”
References
• FDA Approves New Meningitis Vaccine
• Yael Waknine February 23, 2010 Medscape Medical
News © 2010 Medscape, LLC
http://www.medscape.com/viewarticle/717441
• Meningococcal Meningitis Author: Francisco de Assis Aquino
Gondim, MD, MSc, PhD; Chief Editor: Karen L Roos,
MD http://emedicine.medscape.com/article/1165557-overview
Copyright © 1994-2011 by WebMD LLC.
• Cuevas LE, Hart CA. Chemoprophylaxis of bacterial meningitis. J
Antimicrob Chemother. Feb 1993;31 Suppl B:79-91.
• Bader, Mary Kay, & Littlejohns, L.R. (2004). AANN Core Curriculum
for Neuroscience Nursing. Fourth edition. Glenview , IL : American
Association of Neuroscience Nursing.